Results 191 to 200 of about 56,101 (281)

Ischemia–Reperfusion Injury: Molecular Mechanisms and Therapeutic Interventions

MedComm, Volume 7, Issue 7, July 2026.
Multiorgan ischemia–reperfusion injury begins with ischemia‐induced ATP depletion and ionic imbalance, followed by reperfusion‐triggered mitochondrial ROS/RNS bursts, regulated cell death, and DAMP release. Sterile inflammation converges on endothelial–immune–coagulation crosstalk, where NETs drive immunothrombosis, no‐reflow, and remote organ injury ...
Peng An, Yi An, Mengwei Chen, Longlong Wu, Rong Wang   +4 more
wiley   +1 more source

Monovalent antibody treatment of von Willebrand disease. [PDF]

Blood Adv
O'Donnell JS.
europepmc   +1 more source

The need for dried plasma—Still a national issue: Where are we and recommendations

Transfusion, EarlyView.
Anthony E. Pusateri, Shibani Pati, Toby A. Silverman, Roman Dudaryk, Joseph F. Rappold, Lisa Buckley, Andrew P. Cap, Jose A. Cancelas, Laurence M. Corash, G. Michael Fitzpatrick, Michael Ganio, Adam Gerber, Richard Gonzales, Jennifer M. Gurney, Ernest E. Moore, Hunter B. Moore, Vijay Nair, Michael Policastro, Travis M. Polk, Jeffrey W. Shupp, Jason L. Sperry, Ralph R. Vassallo, Therese A. West, John B. Holcomb, Lester Martinez‐Lopez   +24 more
wiley   +1 more source

Clinical Remission of an Unresectable Presumptive Haemangiosarcoma in a Dog Treated With Toceranib, Piroxicam, and Propranolol: A Case Report

Veterinary Medicine and Science, Volume 12, Issue 4, July 2026.
Radiographic remission of a presumptive unresectable haemangiosarcoma treated with toceranib, piroxicam, and propranolol. In a dog with ACVIM Stage B2 myxomatous mitral valve disease where doxorubicin‐based chemotherapy was contraindicated, this multimodal regimen achieved marked tumour reduction and radiographic disappearance.
Woo Dae Park
wiley   +1 more source

HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease. [PDF]

Blood Adv
Häger M, Zivkovic M, Gandhi PS, Rasmussen C, Bonvoisin C, Harrison RA, Poulsen E, Huskens D, Roest M, Ferrara F, Naretto A, Renaud L, Olsen OH, Eskesen NO, Holten-Andersen L, Malladi R, Rea CJ, Sørensen B, Urbanus RT, Østergaard H.   +19 more
europepmc   +1 more source

Cellular Heterogeneity During Arterial Aging

Aging Cell, Volume 25, Issue 7, July 2026.
Graphical abstract showing arterial cell subpopulations and their functional changes during aging. Transcriptomic profiling studies across species identify age‐associated endothelial, smooth muscle, fibroblast, and immune cell states characterized by inflammation, extracellular matrix remodeling, phenotypic switching, and cellular senescence ...
He Xu, Paul‐Lennard Mendez, Dimitri Kasakovski, Judith Sluimer   +3 more
wiley   +1 more source

Clusterin maintains hemostatic equilibrium by stabilizing VWF multimers in plasma.

Blood
Qiao Z, Cao Y, Su J, Lu S, Wei G, Jin S, Ding Q, Sun Y, Huo Y, Dong M, Luo J, Li P.   +11 more
europepmc   +1 more source

Type 3 Von Willebrand disease: two clinical cases of a rare disorder. [PDF]

Oxf Med Case Reports
Belcadi Abassi K, Larbi Ouassou K, Radi A, Laaraje A, Babour S, Ait Hmadouch S, Hassani A, Khorassani MEL, Abilkassem R.   +8 more
europepmc   +1 more source

Mending the blood–brain barrier with photobiomodulation: insights from a humanized tricellular transwell model

The Journal of Physiology, EarlyView.
Alexei Verkhratsky
wiley   +1 more source

Proteolytic remodelling of the extracellular matrix by pericytes

The FEBS Journal, Volume 293, Issue 13, Page 3899-3953, July 2026.
Pericytes are specialised perivascular cells intimately connected with endothelial cells and essential for the maintenance of vascular beds. They contribute to the formation and remodelling of the extracellular matrix by actively secreting proteases and protease inhibitors.
Tina Burkhard, Ella Milne, Kate Qian, Paola Campagnolo, Salvatore Santamaria   +4 more
wiley   +1 more source